Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

BPC-157 and Oxytocin Interaction: Compatible | Peptide Database

Can you take BPC-157 with Oxytocin? Compatible interaction (90% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

BPC-157

Body Protection Compound-157 | Pentadecapeptide

Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..

Oxytocin

Neurohypophysial Peptide | Social Bonding & Reproductive Hormone

Binds oxytocin receptors on uterine smooth muscle, triggering calcium influx and myometrial contractions. Stimulates prostaglandin release.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take BPC-157 with Oxytocin?

Yes, BPC-157 and Oxytocin can generally be taken together. No direct interactions; different mechanisms (tissue repair vs social function).

Is BPC-157 and Oxytocin safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between BPC-157 and Oxytocin?

No direct interactions; different mechanisms (tissue repair vs social function). This assessment has 90% confidence and is based on documented research data.

How should I time BPC-157 and Oxytocin?

BPC-157 has a half-life of <30 minutes and Oxytocin has a half-life of 3-6 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question